Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_assertion type Assertion NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_head.
- NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_assertion wasGeneratedBy ECO_0000203 NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_provenance.
- NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_assertion wasDerivedFrom befree-20150227 NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_provenance.
- NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_assertion SIO_000772 23307186 NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_provenance.
- NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_assertion evidence source_evidence_literature NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_provenance.
- NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_assertion description "[Epidermal growth factor (EGF) receptor (EGFR) mutations are the best illustration of the therapeutic relevance of identifying such molecular clusters of lung cancer based on driver genetic alterations that predict the efficacy of specific tyrosine kinase inhibitors, a strategy referred to as 'personalized medicine.' Besides EGFR and ALK, other genes harboring driver molecular alterations have been identified as part of integrated genomic studies of lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367657.RAAQaWZ3piC7Y16rIWbuMY_fk_M4w334vvt4KBSzUA6Ek130_provenance.